High sensitivity cardiac troponin I detection in physiological environment using AlGaN/GaN High Electron Mobility Transistor (HEMT) Biosensors.

In this study, we report the development of a high sensitivity assay for the detection of cardiac troponin I using electrical double layer gated high field AlGaN/GaN HEMT biosensor. The unique gating mechanism overcomes the drawback of charge screening seen in traditional FET based biosensors, allowing detection of target proteins in physiological solutions without sample processing steps. Troponin I specific antibody and aptamer are used as receptors. The tests carried out using purified protein solution and clinical serum samples depict high sensitivity, specificity and wide dynamic range (0.006-148ng/mL). No additional wash or sample pre-treatment steps are required, which greatly simplifies the biosensor system. The miniaturized HEMT chip is packaged in a polymer substrate and easily integrated with a portable measurement unit, to carry out quantitative troponin I detection in serum samples with < 2µl sample volume in 5min. The integrated prototype biosensor unit demonstrates the potential of the method as a rapid, inexpensive, high sensitivity CVD biomarker assay. The highly simplified protocols and enhanced sensor performance make our biosensor an ideal choice for point of care diagnostics and personal healthcare systems.

[1]  N. Malathi,et al.  Diagnostic markers of acute myocardial infarction. , 2015, Biomedical reports.

[2]  Yaw-Kuen Li,et al.  Silicon nanowire field-effect-transistor based biosensors: from sensitive to ultra-sensitive. , 2014, Biosensors & bioelectronics.

[3]  R. Christenson,et al.  Biomarkers of Myocardial Necrosis , 2006 .

[4]  Gengfeng Zheng,et al.  Multiplexed electrical detection of cancer markers with nanowire sensor arrays , 2005, Nature Biotechnology.

[5]  F. Apple,et al.  Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction , 2015, Clinical chemistry and laboratory medicine.

[6]  A. Jaffe,et al.  Troponin: the biomarker of choice for the detection of cardiac injury , 2005, Canadian Medical Association Journal.

[7]  Yong Duk Han,et al.  A fluoro-microbead guiding chip for simple and quantifiable immunoassay of cardiac troponin I (cTnI). , 2011, Biosensors & bioelectronics.

[8]  Min-Gon Kim,et al.  A dual gold nanoparticle conjugate-based lateral flow assay (LFA) method for the analysis of troponin I. , 2010, Biosensors & bioelectronics.

[9]  P. Collinson,et al.  High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study , 2015, The Lancet.

[10]  D. Lloyd‐Jones,et al.  Multiple biomarker panels for cardiovascular risk assessment. , 2008, The New England journal of medicine.

[11]  Andrew E Moran,et al.  Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013 , 2015, Circulation.

[12]  S. Carrara,et al.  Gold nanoparticles mediated label-free capacitance detection of cardiac troponin I , 2012 .

[13]  N. Stellwagen,et al.  The electric field dependence of DNA mobilities in agarose gels: A reinvestigation , 1990, Electrophoresis.

[14]  Azeem Majeed,et al.  Are cardiovascular disease risk assessment and management programmes cost effective? A systematic review of the evidence. , 2017, Preventive medicine.

[15]  Xuefeng Guo,et al.  Carbon nanomaterials field-effect-transistor-based biosensors , 2012 .

[16]  B. Canaud,et al.  Cardiac troponins and chronic kidney disease , 2010 .

[17]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[18]  C. Ban,et al.  Electrochemical aptasensor of cardiac troponin I for the early diagnosis of acute myocardial infarction. , 2015, Analytical chemistry.

[19]  David J. Mooney,et al.  Label-free biomarker detection from whole blood , 2009, 2010 10th IEEE International Conference on Solid-State and Integrated Circuit Technology.

[20]  Gwo-Bin Lee,et al.  Beyond the Debye length in high ionic strength solution: direct protein detection with field-effect transistors (FETs) in human serum , 2017, Scientific Reports.

[21]  Stefan Blankenberg,et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction. , 2009, The New England journal of medicine.

[22]  A. Singer,et al.  Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3 hours after presentation in early presenters to the emergency department with chest pain. , 2012, American heart journal.

[23]  Il-Hoon Cho,et al.  Chemiluminometric enzyme-linked immunosorbent assays (ELISA)-on-a-chip biosensor based on cross-flow chromatography. , 2009, Analytica chimica acta.

[24]  Yu-Lin Wang,et al.  A Package Technology for Miniaturized Field-Effect Transistor-Based Biosensors and the Sensor Array , 2017 .

[25]  Martin McKee,et al.  Cardiovascular risk and events in 17 low-, middle-, and high-income countries. , 2014, The New England journal of medicine.

[26]  N. Malathi,et al.  Diagnostic markers of acute myocardial infarction (Review) , 2015 .

[27]  Bor-Ran Li,et al.  Silicon nanowire field-effect-transistor based biosensors: from sensitive to ultra-sensitive. , 2014, Biosensors & bioelectronics.

[28]  E. Jameson,et al.  A Study of Blood Serum Proteins by Electrophoresis. , 1939 .

[29]  Guo-Jun Zhang,et al.  Detection of heart failure-related biomarker in whole blood with graphene field effect transistor biosensor. , 2017, Biosensors & bioelectronics.

[30]  Min-Gon Kim,et al.  Development of a surface plasmon resonance-based immunosensor for the rapid detection of cardiac troponin I , 2011, Biotechnology Letters.

[31]  A. Karyakin,et al.  Oriented immobilization of antibodies onto the gold surfaces via their native thiol groups. , 2000, Analytical chemistry.